CAM
MRNA icon

Cozad Asset Management’s Moderna MRNA Stock Holding History

Cozad Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,725
Closed -$265K – 385
2023
Q1 		$265K Hold
1,725
– – 0.04% 322
2022
Q4 		$310K Sell
1,725
-1
-0.1% -$164 0.04% 288
2022
Q3 		$204K Hold
1,726
– – 0.03% 330
2022
Q2 		$247K Buy
1,726
+39
+2% +$5.58K 0.04% 311
2022
Q1 		$291K Buy
1,687
+115
+7% +$19.4K 0.04% 298
2021
Q4 		$399K Buy
1,572
+357
+29% +$104K 0.06% 249
2021
Q3 		$468K Buy
1,215
+120
+11% +$44.3K 0.07% 219
2021
Q2 		$257K Buy
+1,095
New +$196K 0.04% 297

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cozad Asset Management's MRNA Position: Q2 2023 in Review

Cozad Asset Management sold out of Moderna (MRNA) in Q2 2023, closing a stake of 1,725 shares — an estimated $265K sold.

Cozad Asset Management first reported a position in MRNA in Q2 2021 and held it in 8 quarters. The position peaked at $468K in Q3 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Cozad Asset Management reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Cozad Asset Management sold 1,725 Moderna shares in Q2 2023, an estimated $265K.
  • Cozad Asset Management first reported a position in Moderna in Q2 2021 and held it in 8 quarters.
  • Cozad Asset Management's Moderna position peaked at $468K in Q3 2021.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Cozad Asset Management's 13F filing for Q2 2023, filed 26 Jul 2023.